Trump RX Deal: Pfizer to Supply Medicaid Drugs at European Prices
A major move landed in Washington this week: under a plan branded Trump RX, Pfizer agreed to sell many drugs to Medicaid at prices similar to those paid in other developed countries. The White House framed the deal as a win for patients and a blow at high U.S. drug prices, while Pfizer said the deal came with manufacturing and investment commitments.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
